Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
11.51
+0.20 (1.77%)
Nov 21, 2024, 2:24 PM EST - Market open
Company Description
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
The company provides platform for health plan administration and value-based business infrastructure.
It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Evolent Health, Inc.
| Country | United States |
| Founded | 2011 |
| IPO Date | Jun 5, 2015 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 4,700 |
| CEO | Seth Blackley |
Contact Details
Address: 1812 N. Moore Street, Suite 1705 Arlington, Virginia 22209 United States | |
| Phone | 571 389 6000 |
| Website | evolent.com |
Stock Details
| Ticker Symbol | EVH |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001628908 |
| CUSIP Number | 30050B101 |
| ISIN Number | US30050B1017 |
| Employer ID | 32-0454912 |
| SIC Code | 8741 |
Key Executives
| Name | Position |
|---|---|
| Seth Barrie Blackley | Co-Founder, Chief Executive Officer and Director |
| Dan McCarthy | President |
| John Paul Johnson | Chief Financial Officer |
| Emily Rafferty | Chief Operating Officer |
| Jonathan David Weinberg J.D. | Chief Legal Officer, General Counsel and Secretary |
| Aammaad Shams | Chief Accounting Officer |
| Mark Mannion | Senior Vice President of Corporate Finance |
| Robert Cruz | Chief Technology Officer |
| Jessica White | Chief Information Officer |
| Seth R. Frank | Vice President of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | 10-Q | Quarterly Report |
| Nov 7, 2024 | 8-K | Current Report |
| Aug 23, 2024 | 144/A | Filing |
| Aug 22, 2024 | 144 | Filing |
| Aug 22, 2024 | 144 | Filing |
| Aug 22, 2024 | 144 | Filing |
| Aug 22, 2024 | 144 | Filing |
| Aug 9, 2024 | 10-Q | Quarterly Report |
| Aug 8, 2024 | 8-K | Current Report |